Article

Association of the 12-gene Breast DCIS Score® assay with local recurrence in patients with ductal carcinoma in situ treated on accelerated partial breast radiotherapy protocols

2020-12-19

Abstract excerpt

<h4>Background: </h4> The following analysis explores clinicopathologic factors and the 12-gene Breast DCIS Score test result in order to better define an appropriate DCIS (ductal carcinoma in situ) population eligible for APBI (accelerated partial breast radiotherapy). Methods This exploratory analysis aimed to retrospectively measure the association between the 12-gene Oncotype DX Breast DCIS Score® assay (Redw...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: cd3447dc-cdc2-5167-8c53-b811ffb9ae6b
DOI: 10.21203/rs.3.rs-116082/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Association of the 12-gene Breast DCIS Score® assay with local recurrence in patients with ductal carcinoma in situ treated on accelerated partial breast radiotherapy protocolsDOI 10.21203/rs.3.rs-116082/v1Read

Disease Recurrence in Patients Undergoing Mastectomy for Ductal Carcinoma In SituSemantic proximity Read

DCIS genomic signatures define biology and clinical outcome: Human Tumor Atlas Network (HTAN) analysis of TBCRC 038 and RAHBT cohortsSemantic proximity Read

Molecular phenotypes of DCIS predict overall and invasive recurrence.Semantic proximity Read

Development and Validation of a Multimodal Clinical, Pathologic, and Genomic Model for Breast Cancer RecurrenceSemantic proximity Read

Mutational landscape of pure ductal carcinoma in situ and associations with disease prognosis and response to radiotherapySemantic proximity Read

PreciseBreast is prognostic for breast cancer recurrence in a 21-gene assay managed cohortSemantic proximity Read

Oncotype-DX recurrence score distribution in breast cancer patients with BRCA1/2 mutations.Semantic proximity Read

Genomic profiling reveals heterogeneous populations of ductal carcinoma in situ of the breastSemantic proximity Read

Clinical outcomes and Oncotype DX Breast Recurrence Score® in early-stage BRCA-associated hormone receptor-positive breast cancer.Semantic proximity Read

Utilization and impact of 21-gene recurrence score assay for breast cancer in clinical practice across the United States: lessons learned from the 2010 to 2012 National Cancer Data Base analysis.Semantic proximity Read

High concordance of 70-gene recurrence risk signature and 80-gene molecular subtyping signature between core needle biopsy and surgical resection specimens in early-stage breast cancerSemantic proximity Read

Genomic profiling reveals heterogeneous populations of ductal carcinoma in situ of the breast.Semantic proximity Read